Raymond James & Associates’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-27,800
| Closed | -$93K | – | 3688 |
|
|
2019
Q4 | $93K | Sell |
27,800
-300
| -1% | -$1K | ﹤0.01% | 3438 |
|
|
2019
Q3 | $85K | Buy |
28,100
+100
| +0.4% | +$302 | ﹤0.01% | 3368 |
|
|
2019
Q2 | $67K | Hold |
28,000
| – | – | ﹤0.01% | 3421 |
|
|
2019
Q1 | $105K | Buy |
28,000
+100
| +0.4% | +$375 | ﹤0.01% | 3348 |
|
|
2018
Q4 | $100K | Sell |
27,900
-9,600
| -26% | -$34.4K | ﹤0.01% | 3280 |
|
|
2018
Q3 | $215K | Sell |
37,500
-4,300
| -10% | -$24.7K | ﹤0.01% | 3234 |
|
|
2018
Q2 | $209K | Buy |
41,800
+3,300
| +9% | +$16.5K | ﹤0.01% | 3223 |
|
|
2018
Q1 | $198K | Hold |
38,500
| – | – | ﹤0.01% | 3119 |
|
|
2017
Q4 | $231K | Sell |
38,500
-4,000
| -9% | -$24K | ﹤0.01% | 2958 |
|
|
2017
Q3 | $236K | Hold |
42,500
| – | – | ﹤0.01% | 2924 |
|
|
2017
Q2 | $197K | Buy |
42,500
+500
| +1% | +$2.32K | ﹤0.01% | 2965 |
|
|
2017
Q1 | $208K | Buy |
42,000
+1,000
| +2% | +$4.95K | ﹤0.01% | 2891 |
|
|
2016
Q4 | $455K | Sell |
41,000
-4,200
| -9% | -$46.6K | ﹤0.01% | 2385 |
|
|
2016
Q3 | $419K | Buy |
+45,200
| New | +$419K | ﹤0.01% | 2388 |
|